TSPAN8 and ovarian carcinoma: TSPAN8 was originally identified as a human tumor-associated antigen found to be overexpressed in many different epithelial cancers, including lung, liver, gastric, esophageal, colorectal, and ovarian carcinomas [130,160,161].